A third dose boosted cross-protection against SARS-CoV-2 viral variants, finds study

Transplant recipients must take life-long immunosuppressive medications to prevent rejection, but these drugs can compromise the effectiveness of vaccines.

The biotech news roundup to start your week

This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Morning! Today, we see even

November 4, 2024

Exclusive: Siduma, a biotech from Arvinas’ scientific founder, shutters due to ‘financing environment’

Siduma Therapeutics, a Yale spinout from Arvinas scientific founder Craig Crews, has closed, a spokesperson for the company confirmed to Endpoints News via email Thursday.

April 13, 2024

Bessemer VC Morgan Cheatham shares how AI healthcare startups can win in a crowded market

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Among what seems like … Sign up

July 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.